TCI Wealth Advisors’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1
| Closed | -$440 | – | 386 |
|
|
2023
Q1 | $440 | Hold |
1
| – | – | ﹤0.01% | 2238 |
|
|
2022
Q4 | $1.27K | Hold |
1
| – | – | ﹤0.01% | 2077 |
|
|
2022
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 2035 |
|
|
2022
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 1963 |
|
|
2022
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 1952 |
|
|
2021
Q4 | $5K | Hold |
1
| – | – | ﹤0.01% | 1622 |
|
|
2021
Q3 | $7K | Hold |
1
| – | – | ﹤0.01% | 1315 |
|
|
2021
Q2 | $10K | Hold |
1
| – | – | ﹤0.01% | 924 |
|
|
2021
Q1 | $9K | Hold |
1
| – | – | ﹤0.01% | 869 |
|
|
2020
Q4 | $8K | Hold |
1
| – | – | ﹤0.01% | 677 |
|
|
2020
Q3 | $7K | Hold |
1
| – | – | ﹤0.01% | 642 |
|
|
2020
Q2 | $8K | Hold |
1
| – | – | ﹤0.01% | 603 |
|
|
2020
Q1 | $7K | Hold |
1
| – | – | ﹤0.01% | 619 |
|
|
2019
Q4 | $16K | Hold |
1
| – | – | 0.01% | 591 |
|
|
2019
Q3 | $10K | Hold |
1
| – | – | ﹤0.01% | 634 |
|
|
2019
Q2 | $16K | Hold |
1
| – | – | 0.01% | 508 |
|
|
2019
Q1 | $17K | Hold |
1
| – | – | 0.01% | 514 |
|
|
2018
Q4 | $10K | Hold |
1
| – | – | ﹤0.01% | 609 |
|
|
2018
Q3 | $14K | Hold |
1
| – | – | 0.01% | 561 |
|
|
2018
Q2 | $13K | Hold |
1
| – | – | 0.01% | 586 |
|
|
2018
Q1 | $13K | Hold |
1
| – | – | 0.01% | 561 |
|
|
2017
Q4 | $10K | Hold |
1
| – | – | ﹤0.01% | 626 |
|
|
2017
Q3 | $3K | Hold |
1
| – | – | ﹤0.01% | 825 |
|
|
2017
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 962 |
|
|
2017
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 911 |
|
|
2016
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 891 |
|
|
2016
Q3 | $13K | Buy |
+1
| New | +$13K | 0.01% | 511 |
|